DEBORAH LAVIN: Open Payments
NPI 1720099336 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 15 payments from 7 companies in 2025. Trend: 2023 $815 · 2024 $355 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $87 |
| PFIZER INC. | 2 | $49 |
| Boston Scientific Corporation | 2 | $42 |
| Amgen Inc. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: WATCHMAN, REPATHA, LEQVIO, CAMZYOS, ELIQUIS, VYNDAQEL, LifeVest, LOKELMA.
Industry payments across NY — which companies pay providers there.
